Delivery Order SPE2DB22D3501-SPE2DB25FUZ73
Award Date
3/21/25
Potential Completion Date
3/24/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,020.80, is for the delivery of GONAL-F RFF REDI-JECT 900 unit 1.5ML medical products. It is a firm-fixed-price delivery order contract with a completion date of December 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $10,396.00 firm fixed price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December...
This federal contract award is a $1,097.50 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a medication, with a performance period through June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $10,681.56, was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, a medical product, with a completion date of November 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp is the prime contractor and holds a...
This federal contract award, valued at $93,128.18, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, with a performance period ending on May 14, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,097.52 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $27,298.26, is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML pharmaceutical products. It is a Firm Fixed Price Delivery Order contract with a completion date of May 28, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $70,865.15, is for the delivery of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, a pharmaceutical product, with a performance period ending on May 2, 2025. This contract is not designated as a set-aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor in the United States. The $60,276.29 fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a medication used in fertility treatments. The contract has an ultimate completion date of August 29, 2024 and was awarded on August 28, 2024. This contract is not designated as a set-aside. Amerisourcebergen, through its...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, a pharmaceutical product, with a ceiling value of $1,097.48 and a period of performance through June 26, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....